Literature DB >> 5505090

Indomethacin and urinary excretion of fibrinogen-like material in proliferative glomerulonephritis.

J Vermylen, G Dotremont, G de Gaetano, M B Donati, P Michielsen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5505090

Source DB:  PubMed          Journal:  Rev Eur Etud Clin Biol        ISSN: 0035-3019


× No keyword cloud information.
  9 in total

Review 1.  Bright's disease today: the pathogenesis and treatment of glomerulonephritis. 3.

Authors:  J S Cameron
Journal:  Br Med J       Date:  1972-10-28

2.  Immunologically reactive equivalents of fibrinogen in sera and urine of children with renal disease.

Authors:  H Ekert; T M Barratt; C Chantler; M W Turner
Journal:  Arch Dis Child       Date:  1972-02       Impact factor: 3.791

3.  Modification by drugs of urinary fibrin/fibrinogen degradation products in glomerulonephritis.

Authors:  A R Clarkson; M K MacDonald; J D Cash; J S Robson
Journal:  Br Med J       Date:  1972-07-29

4.  Serum and urinary fibrin-fibrinogen degradation products in glomerulonephritis.

Authors:  A R Clarkson; M K MacDonald; J J Petrie; J D Cash; J S Robson
Journal:  Br Med J       Date:  1971-08

Review 5.  Platelets, thrombosis and drugs.

Authors:  J F Mustard; M A Packham
Journal:  Drugs       Date:  1975       Impact factor: 9.546

6.  Indomethacin and platelet aggregation in chronic glomerulonephritis: existence of non-responders.

Authors:  G De Gaetano; J Vermylen; M B Donati; G Dotremont; P Michielsen
Journal:  Br Med J       Date:  1974-05-11

Review 7.  Current issues in thrombosis prevention with antiplatelet drugs.

Authors:  G de Gaetano; C Cerletti; E Dejana; J Vermylen
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

8.  Indomethacin and gentamycin treatment in experimental kidney infection.

Authors:  S Túri; J Sallai; E Farkas; G Petheö
Journal:  Int Urol Nephrol       Date:  1982       Impact factor: 2.370

9.  Detection of fibrinogen antigens with two latex techniques applied to urine concentrates.

Authors:  M B Donati; N Semeraro; J Vermylen
Journal:  J Clin Pathol       Date:  1973-10       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.